The New York Times reported yesterday that many of the authors of the DSM-IV, the sine qua non diagnostic manual (I’m 300.00, thanks for asking) for mental health professionals had ties, either before or after their involvement in creating the manual, with the pharmaceutical industry. The implication being that there was something wrong with this.
Now, I realize there is a potential conflict of interest here. But don’t we want the DSM consulting people who know about drugs that can treat mental health problems? And don’t we want drug makers consulting experts on mental health? How do we keep the last two without falling into the dangers of the first?